ÂÜÀòÂÒÂ×

Dan Wolf, PhD, MBA, is an accomplished professional in the field of clinical development and medical affairs with extensive experience in the biotechnology and pharmaceutical industries. Currently serving as Senior Director of Clinical Development at Dyne Therapeutics, Dan has previously held key positions at Sarepta Therapeutics, including Director of Clinical Development and Associate Director of Global Medical Affairs Lead for CNS and Neuromuscular Gene Therapy. Dan's career began at Biogen as a Medical Science Liaison focusing on Spinal Muscular Atrophy and involved roles in Global Biomarker Discovery and Clinical Research. Dan's research foundations were established at Lund University as a Postdoctoral Research Fellow and the University of Minnesota as a Graduate Research Assistant. Academic credentials include a PhD in Molecular from the University of Minnesota and an MBA from Worcester Polytechnic Institute, where the emphasis was on The Innovator's MBA.